SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030747
Filing Date
2019-08-08
Accepted
2019-08-08 16:01:24
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arpo-10q_20190630.htm 10-Q 1660900
2 EX-31.1 arpo-ex311_7.htm EX-31.1 20432
3 EX-31.2 arpo-ex312_9.htm EX-31.2 21661
4 EX-32.1 arpo-ex321_8.htm EX-32.1 10582
5 EX-32.2 arpo-ex322_6.htm EX-32.2 11822
  Complete submission text file 0001564590-19-030747.txt   5181536

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arpo-20190630.xml EX-101.INS 1010947
7 XBRL TAXONOMY EXTENSION SCHEMA arpo-20190630.xsd EX-101.SCH 35813
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arpo-20190630_cal.xml EX-101.CAL 31453
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arpo-20190630_def.xml EX-101.DEF 85302
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20190630_lab.xml EX-101.LAB 293546
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20190630_pre.xml EX-101.PRE 220266
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 191009388
SIC: 2834 Pharmaceutical Preparations